Amiodarone-induced bronchiolitis obliterans organizing pneumonia (BOOP)

Respiratory Medicine

Volumn 90, Issue 3, 1996, Pages 167-169

  Oren, S ^a   Turkot, S ^a   Golzman, B ^a   London, D ^a   Ben Dor, D ^a   Weiler, Z ^a  

^a BARZILAI MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

ADULT; ARTICLE; BRONCHIOLITIS; CASE REPORT; HUMAN; HUMAN CELL; LUNG TOXICITY; MALE; ORGANIZING PNEUMONIA; PRIORITY JOURNAL;

EID: 0029928281     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(96)90159-6     Document Type: Article

References (18)

1. Dusman RE, Stanton MSS, Miles WM et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990; 82: 51-59.
2. Akoun GM, Milleron BJ, Badaro DM, Mayaud CM, Liote HA. Pleural T-lymphocyte subsets in amiodarone-associated pleuropneumonitis. Chest 1989; 95: 596-597.
3. Pichler WJ, Schindler L, Staubli M, Stadler BM, de Weck AL. Anti-amiodarone antibodies: detection and relationship to the development of side effects. Am J Med 1988; 85: 197-202.
4. Heger JJ, Prystowsky EN, Zipes DP. Relationships between amiodarone dosage, drug concentrations, and adverse side effects. Am Heart J 1983; 106: 931-935.
5. Falik R, Flores BT, Shalw L, Gibson GA, Josephson ME, Marchlinski FE. Relationship of steady-state serum amiodarone concentrations: relationships with antiarrhythmic efficacy and toxicity. Ann Intern Med 1987; 82: 1102-1108.
6. Martin WJ II, Howard DM. Amiodarone-induced lung toxicity: in vitro evidence for the direct toxicity of the drug. Am J Pathol 1986; 120: 344-350.
7. Marchlinski FE, Gansler TS, Waxman HL, Josephson ME. Amiodarone pulmonary toxicity. Ann Intern Med 1982; 97: 839-845.
8. Magro SA, Lawrence EC, Wheeler SH, Krafchek J, Lin HT, Wyndham CRC. Amiodarone pulmonary toxicity: prospective evaluation of serial pulmonary function tests. J Am Coll Cardiol 1988; 12: 781-788.
9. Kudenchuk PJ, Pierson DJ, Greene HL, Graham EL, Sears GK, Troubaugh GB. Prospective evaluation of amiodarone pulmonary toxicity. Chest 1984; 86: 541-548.
10. Dean PJ, Groshart KD, Porterfield JG, Iansmith DH, Golden EB. Amiodarone-associated pulmonary toxicity: a clinical and pathologic study of eleven cases. Am J Clin Pathol 1987; 87: 7-13.
11. Martin WJ, Rosenow EC. Amiodarone pulmonary toxicity. Recognition and pathogenesis. Chest 1988; 93: 1067-1075.
12. Kuhlman JE, Teigen C, Ren H et al. Amiodarone pulmonary toxicity: CT findings in symptomatic patients. Radiology 1990; 177: 121-125.
13. Akoun GM, Cadranel JL, Blanchette G, Milleron BJ, Mayaud CM. Bronchoalveolar lavage cell data in amiodarone-associated pneumonitis. Evaluation in 22 patients. Chest 1991; 99: 1177-1182.
14. Ren H, Kuhlman JE, Hruban RH, Fishman EK, Wheeler PS, Hutchins GM. CT-pathology correlation of amiodarone lung. J Comput Assist Tomogr 1990; 14: 760-765.
15. Epler GR, Ciolby TV, Mcloud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985; 312: 152-158.
16. Kitaichi M. Differential diagnosis of bronchiolitis obliterans organizing pneumonia. Chest 1992; 102 (suppl.): 44S-49S.
17. Epler GR. Bronchiolitis obliterans organizing pneumonia: definition and clinical features. Chest 1992; 102 (suppl.): 2S-6S.
18. Camus P, Lombard JN, Perrichon M et al. Bronchiolitis obliterans organizing pneumonia in patients taking acebutolol or amiodarone. Thorax 1989; 44: 711-715.